MyFinsight
Home
Blog
About
Net change in cash
-$23,934K
(-265.60%↓ Y/Y)
Inventory
-$5,298K
(-589.20%↓ Y/Y)
Credit loss expense
$5,281K
(383.17%↑ Y/Y)
Depreciation and
amortization
$1,531K
(-75.97%↓ Y/Y)
Other assets
-$1,270K
(-156.17%↓ Y/Y)
Share-based compensation
$903K
(-89.98%↓ Y/Y)
Non-cash lease expenses
$334K
(-46.04%↓ Y/Y)
Accrued expenses
$218K
(-93.82%↓ Y/Y)
Other
$104K
(-64.63%↓ Y/Y)
Net cash flows used
in financing...
-$13,284K
(-234.44%↓ Y/Y)
Net cash flows (used
in) provided by...
-$10,015K
(-150.79%↓ Y/Y)
Net cash flows used
in investing...
-$635K
(50.89%↑ Y/Y)
Canceled cashflow
$14,939K
Cash paid for share
repurchases pursuant to...
$12,468K
Principal payments on
citizens term loan...
-$375K
(25.00%↑ Y/Y)
Cash paid for profit
share payment (note...
$298K
(-38.93%↓ Y/Y)
Stock repurchased for
tax withholdings on...
$127K
(-95.74%↓ Y/Y)
Deferred financing cost
$16K
Net (loss) income
-$14,840K
(-189.19%↓ Y/Y)
Purchases of equipment
$598K
(7.55%↑ Y/Y)
Patent application
costs
$37K
(0.00%↑ Y/Y)
Accounts payable
-$3,170K
(-500.25%↓ Y/Y)
Deferred income taxes
$3,168K
(448.90%↑ Y/Y)
Other liabilities
-$1,882K
(-76.38%↓ Y/Y)
Accrued compensation
-$1,349K
(-70.54%↓ Y/Y)
Accounts receivable
$545K
(-96.24%↓ Y/Y)
Back
Back
Cash Flow
MIMEDX GROUP, INC. (MDXG)
MIMEDX GROUP, INC. (MDXG)
source: myfinsight.com